Figure 1.
TGF-β pathways in MDS: Various ligands belonging to the TGF-β pathway bind to activin-like kinase (ALK) receptors and activate SMAD proteins. SMAD proteins act as transcription factors and regulate important hematopoietic genes that are altered in MDS. ActRIIA, activin receptor type IIA; ActRIIB, ActRIIB.